EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Inflammatory Myopathies

Yves Allenbach, Olivier Benveniste iD

New England Journal of Medicine · 14.05.2026 · 394 (19) · 1925-1938

DOI: 10.1056/nejmra2415426 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift New England Journal of Medicine, erschienen am 14.05.2026. Verfasst von Yves Allenbach und 1 weiteren Autor:innen. Beteiligte Einrichtung: Centre National de Référence des Myopathies Inflammatoires, Département de Médecine Interne et Immunologie Clinique, Groupe Hospitalier Pitié-Salpêtr…. Hauptthemen laut MEDLINE: Autoantibodies, Myositis, Autoimmune Diseases. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 81 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Inflammatory myopathies are a heterogeneous group of autoimmune diseases characterized by immune-mediated damage to skeletal muscle. They are classified into five major subtypes: inclusion-body myositis, immune-mediated necrotizing myopathies, antisynthetase syndrome, overlapping myositis, and dermatomyositis, each with distinct clinical features and outcomes. Inclusion-body myositis and immune-mediated necrotizing myopathies primarily affect muscle, with prognosis largely determined by functional impairment, whereas antisynthetase syndrome, overlapping myositis, and dermatomyositis are systemic diseases that can involve the skin, joints, and lungs and may be life-threatening. The majority of inflammatory myopathies are associated with myositis-specific autoantibodies, which inform diagnosis, subtype classification, and prognosis. Advances in understanding the distinct pathomechanisms underlying each subgroup now enable increasingly targeted therapeutic approaches.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AutoantibodiesMyositisAutoimmune DiseasesHumansDermatomyositisMuscle, SkeletalMyositis, Inclusion BodyPrognosisMagnetic Resonance ImagingSkinJointsDiagnosis, DifferentialImmunoglobulins, IntravenousGlucocorticoidsRituximabImmunologic FactorsDrug Therapy, CombinationLymphocyte DepletionLung

Substanzen

AutoantibodiesImmunoglobulins, IntravenousGlucocorticoidsRituximabImmunologic Factors

Autor:innen und Institutionen

  • Centre National de Référence des Myopathies Inflammatoires, Département de Médecine Interne et Immunologie Clinique, Groupe Hospitalier Pitié-Salpêtrière, Assistance Publique-Hôpitaux de Paris.
  • Team Inflammatory Myopathies at the Research Center in Myology, Sorbonne Université, INSERM UMR974, Paris.

ORCID-Profile: Olivier Benveniste

Zitieren

APA

Allenbach, Y., & Benveniste, O. (2026). Inflammatory Myopathies. New England Journal of Medicine, 394(19), 1925-1938. https://doi.org/10.1056/nejmra2415426

Vancouver

Allenbach Y, Benveniste O. Inflammatory Myopathies. New England Journal of Medicine. 2026;394(19):1925-1938. doi:10.1056/nejmra2415426

BibTeX
@article{Allenbach2026,
  author = {Allenbach, Yves and Benveniste, Olivier},
  title = {Inflammatory Myopathies},
  journal = {New England Journal of Medicine},
  year = {2026},
  volume = {394},
  number = {19},
  pages = {1925--1938},
  doi = {10.1056/nejmra2415426}
}
Kostenlos starten →